Myeloablative 131I-tositumomab radioimmunotherapy in treating non-Hodgkin's lymphoma: comparison of dosimetry based on whole-body retention and dose to critical organ receiving the highest dose.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples